Skip to main content
. 2019 May 3;9:341. doi: 10.3389/fonc.2019.00341

Figure 1.

Figure 1

(A) HBD-1,-2, and−3 either increased (red arrow) or decreased (green arrow) in cancers from different anatomical locations within human body (as indicated). (B) HBD-1,-2, and−3 either promote (red arrow) or inhibit (green arrow) migration/proliferation of cancers cells derived from different anatomical locations (as indicated). (C) Effector molecules/pathways by which each of the three defensins (hBD-1,−2, and−3) are dysregulated in cancers.